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Background
A panorama of mucocutaneous manifestations is pro-
duced by HIV infection which correlates with the degree
of immunodeficiency. Viral, bacterial and fungal infections,
as well as inflammatory skin diseases, have all been
reported to increase as CD4 T cells are depleted. Since the
introduction of HAART, there has been a dramatic
decrease in the incidence of HIV associated dermatoses.
However, initiation of ART itself causes various cutaneous
adverse effects. Our goal was to study the various mucocu-
taneous manifestations encountered in treatment naïve
HIV infected and those on ART.
Methods
This study involved a cross sectional assessment of 85 HIV
seropositive patients attending STD and ART clinic.
Of which 16 patients were not on HAART and the rest 69
were on HAART.
Results
The mean baseline CD4 count of those not on HAART
was 571.94±278.44 and mean baseline CD4 count of
those on HAART was 281.88± 231.02 and the difference
was significant (p<0.0001). Six months post HAART, the
mean CD4 count had significantly increased to 515.44±
245.54 (p<0.001). The incidence of mucocutaneous
manifestations were similar in both the groups
(p=0.4891). The most common infections in those not
on HAART were fungal (25%), viral (12.5%), bacterial
(6%). And among those on HAART were fungal (43%),
viral(25.5%) and bacterial(2.8%). The various adverse
cutaneous reactions to HAART observed in our study
were lipodystrophy (14%), maculopapular rash(7.2%)
lichenoid eruptions(5.2%).
Conclusion
These findings indicate that HAART often reduces the
incidence of infectious skin diseases in patients with HIV,
but can itself be the cause of drug eruptions.
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